Tom Nolan reviews this week’s research “Small individual gain, larger population gain” sounds like the theme for a preventive medicine conference. It’s actually the headline of an editorial about a ...

Opens in a new tab or window Intravenous zoledronate (Reclast) administered once every 5 years reduced the incidence of morphometric vertebral fractures in early postmenopausal women, a randomized ...

Using data from 638,999 patients, a new study by a research team at the Warren Alpert Medical School found that the incidence ...

Whether infrequent zoledronate administration would prevent vertebral fractures in early postmenopausal women is unknown. We conducted a 10-year, prospective, double-blind, randomized, placebo ...

For early postmenopausal women, zoledronate administered at baseline and five years is effective for preventing morphometric vertebral fracture, according to a study published in the Jan. 16 issue ...

An 81-year-old man with longstanding ankylosing spondylitis presented to the emergency department with pain in his lower back 2 days after a fall from standing height. The pain from the injury made it ...

After missing all of last season due to a fractured vertebra, Ayden Madi has helped Brophy Prep basketball make a run to the ...

Two tiger cubs were found dead in Wayanad Wildlife Sanctuary, killed by another tiger. The cubs, a male and female, showed ...

For early postmenopausal women, zoledronate administered at baseline and 5 years is effective for preventing morphometric vertebral fracture.

WEDNESDAY, Jan. 15, 2025 (HealthDay News) -- For early postmenopausal women, zoledronate administered at baseline and five years is effective for preventing morphometric vertebral fracture ...